Purchase Order HHSN269201400051P

The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $638,800.00 firm fixed-price purchase order to Fujifilm Wako Automation Corporation, a foreign-owned for-profit company, to provide a WAKO AUTOMATION USA, INC. 1 YOKOGAWA CW7000 HIGH-THROUGHPUT MICROSCOPY SYSTEM. The award was not set aside and Fujifilm Wako Automation Corporation was the prime contractor. Fujifilm Wako Automation Corporation develops and markets automated systems and...

This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Akina, Inc., a minority-owned, for-profit Asian-Pacific American manufacturer, for the development of "NEW ANALYTICAL METHODS FOR COMPLEX SAMENESS OF INJECTABLE, LONG-ACTING PLGA FORMULATIONS" under Broad Agency Announcement (BAA) PMQWP#187. The contract, with a firm fixed price of $992,304.63, was awarded on September 25, 2019, and has a completion date of...

This is a non-competitive, Firm Fixed Price purchase order awarded by the National Institutes of Health's (NIH) National Center for Advancing Translational Sciences (NCATS) to Fujifilm Wako Chemicals U.S.A. Corporation, doing business as Fujifilm Wako Chemicals USA Corp, for the purchase of one LGR Precise Drop II System and the upgrade of one BioRaptr unit for a total ceiling value of $98,848.00. The purchase order is to provide micro- to nanoliter dispensing systems and...

This is a firm fixed-price BPA call contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Fujifilm Wako Chemicals U.S.A. Corporation. The contract is for the purchase of extracellular vesicle isolation kits to be used for isolating extracellular vesicles from cell culture and fecal samples. The contract has a ceiling value of $5,057.50 and a completion date of August 31, 2017. Fujifilm Wako Chemicals U.S.A. Corporation...

The U.S. Food and Drug Administration (FDA) awarded a $106,675.00 firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, for a proteomic analysis of cancer patient plasma samples. The contract, which has no set-aside designation, will be performed at Olink's facility in Waltham, Massachusetts and involves the comprehensive analysis of over 5,000 proteins across 100 plasma samples using Olink's advanced multiplex immunoassay...

The National Cancer Institute awarded a service contract valued at $16,870 to Global Life Sciences Solutions USA LLC for Dr. Lee's Fluorescence Protein Labeling and Characterization System (FPLCS) on December 21, 2022, with an ultimate completion date of December 20, 2023. This firm fixed-price contract was issued as a Blanket Purchase Agreement (BPA) call with no small business set-aside designation. The work will be performed in Marlborough, Massachusetts, where Global Life Sciences...

This is a $25,956.00 firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Takara Bio USA, Inc., a for-profit manufacturer of specialized biomedical products and services. The contract is for the period of February 24, 2016 to July 15, 2016, and does not have a small business set-aside designation. Takara Bio USA, Inc. is a prime contractor providing the National Cancer Institute with research tools...

Global Life Sciences Solutions USA LLC, a wholly owned subsidiary of Danaher Corporation, was awarded a firm fixed-price purchase order valued at $6,452.00 for a fullcare service agreement on a Typhoon FLA 7000 imaging system (serial number 28983618-1672147-1). The contract was awarded on October 24, 2014, by a civilian federal agency operating from the Southeast Area, with performance conducted in Stoneville, Mississippi, and a completion date of September 30, 2015. This award utilized no small...

This contract award represents a Blanket Purchase Agreement (BPA) call issued by the National Cancer Institute (NCI), a component of the National Institutes of Health, to Global Life Sciences Solutions USA LLC for full care service agreement related to AKTA FPLC laboratory equipment without FRAC functionality. The award, made on May 1, 2017, carries a ceiling value of $11,054.38 under a firm fixed-price structure with an ultimate completion date of December 31, 2017. The work will be performed...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed-price purchase order to Fujifilm Wako Chemicals U.S.A. Corporation, a subsidiary of FUJIFILM Holdings America Corp, to upgrade the National Center for Advancing Translational Sciences' (NCATS) current robotic screening platform. The $242,200.00 contract aims to increase the platform's capabilities to allow for Labcyte (now Beckman) acoustic...